Phraction Management’s Boston Scientific BSX Stock Holding History

Phraction Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.51M	Sell	34,693 -1,865	-5%	-$86.3K	0.28%	37
2026 Q2	$1.56M	Sell	36,558 -50	-0.1%	-$2.72K	0.26%	38
2026 Q1	$2.3M	Buy	+36,608	New	+$2.93M	0.48%	34
2022 Q4	–	Sell	-12,205	Closed	-$473K	–	49
2022 Q3	$473K	Sell	12,205 -20,000	-62%	-$802K	0.36%	39
2022 Q2	$1.2M	Buy	32,205 +525	+2%	+$21.4K	0.79%	36
2022 Q1	$1.4M	Buy	31,680 +940	+3%	+$40.7K	0.81%	39
2021 Q4	$1.31M	Buy	+30,740	New	+$1.29M	0.79%	35

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Phraction Management's BSX Position: Q3 2026 in Review

Phraction Management reduced its Boston Scientific (BSX) stake by 5.1% in Q3 2026, selling an estimated $86.3K and leaving 34,693 shares worth $1.51M. The position accounts for 0.28% of the portfolio, ranked #37.

Phraction Management first reported a position in BSX in Q4 2021 and has held it in 7 quarters since. The position peaked at $2.3M in Q1 2026. 335 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Phraction Management held 34,693 shares of Boston Scientific worth $1.51M as of Q3 2026.
Phraction Management sold 1,865 Boston Scientific shares in Q3 2026, an estimated $86.3K.
Boston Scientific made up 0.28% of Phraction Management's portfolio in Q3 2026, its #37 holding.
Phraction Management first reported a position in Boston Scientific in Q4 2021 and has held it in 7 quarters since.
Phraction Management's Boston Scientific position peaked at $2.3M in Q1 2026.
335 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Phraction Management's 13F filing for Q3 2026, filed 14 Oct 2026.